QFRD - ETF AI Analysis
Top Page
Pacer S&P 500 Quality FCF R&D Leaders (QFRD)
Rating:74Outperform
Price Target:―
Positive Factors
Strong Recent Short-Term Performance
The ETF has shown strong gains over the past month and solid results over the last three months, indicating positive recent momentum.
Exposure to Innovative Growth Sectors
With most of its holdings in technology and health care, the fund is tilted toward sectors that can benefit from innovation and long-term growth trends.
High-Quality Growth Leaders in Top Holdings
Several major positions, such as Synopsys, Cadence Design, AMD, and Meta Platforms, have delivered strong year-to-date performance, helping support the fund’s returns.
Negative Factors
High Sector Concentration
The ETF is heavily concentrated in technology and health care, which increases the risk if these sectors experience a downturn.
Weakness in Several Top Holdings
A number of the largest positions, including Coinbase, Datadog, Incyte, Electronic Arts, Vertex, and Workday, have shown weak year-to-date performance, which can drag on overall results.
Relatively High Expense Ratio for an ETF
The fund’s expense ratio is on the higher side for an ETF, meaning more of the return is lost to fees compared with lower-cost alternatives.
QFRD vs. SPDR S&P 500 ETF (SPY)
AUM1.12M
RegionNorth America
Expense Ratio0.49%
Beta0.99
IssuerPacer
Inception DateJan 12, 2026
Dividend Yield0.11%
Asset ClassEquity
Index TrackedS&P 500 Quality FCF R&D Leaders Index - USD - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume46
30 Day Avg. Volume129
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.41Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QFRD Summary
QFRD is an ETF that follows the S&P 500 Quality FCF R&D Leaders Index, focusing on about 50 large U.S. companies that spend heavily on research and development while also generating strong cash flow. It leans toward innovative sectors like technology and healthcare, with well-known holdings such as Meta Platforms and Advanced Micro Devices (AMD). An investor might consider QFRD for growth potential and diversification within high-quality, innovation-driven companies. However, it is heavily tilted toward tech and healthcare, so its price can swing more than the overall market and may fall if these sectors struggle.
How much will it cost me?This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 you invest. That’s higher than the cost of a typical broad, passively managed S&P 500 index fund because this ETF tracks a more specialized index that focuses on a smaller group of R&D-focused, high-quality companies.
What would affect this ETF?QFRD could benefit if the U.S. economy stays resilient, tech and healthcare innovation remains strong, and lower interest rates or supportive regulations make it easier for its R&D‑heavy companies to grow and turn new ideas into profits. On the other hand, it could be hurt by rising interest rates that pressure growth stocks, tighter rules on big tech or digital assets, or a downturn that hits its concentrated U.S. technology and healthcare holdings harder than the broader market.
QFRD Top 10 Holdings
QFRD is leaning hard into U.S. innovation, with a tech-heavy lineup doing most of the heavy lifting. Datadog, AMD, and Palo Alto Networks have been rising smartly, giving the fund a strong push from cloud, chips, and cybersecurity. Cadence and CrowdStrike are also helping, though their rich valuations keep sentiment a bit cautious. On the softer side, Synopsys has been more mixed and Workday is clearly lagging, acting as a small brake on returns. Overall, this is a concentrated bet on U.S. tech and healthcare R&D leaders rather than a broad market sampler.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Datadog | 6.48% | $72.64K | $92.68B | 74.98% | 69 Neutral | |
| Advanced Micro Devices | 4.02% | $45.05K | $844.36B | 274.48% | 73 Outperform | |
| CrowdStrike Holdings | 3.95% | $44.23K | $197.52B | 53.33% | 67 Neutral | |
| Palo Alto Networks | 3.79% | $42.46K | $283.67B | 65.22% | 73 Outperform | |
| Cadence Design | 3.73% | $41.79K | $102.92B | 14.78% | 78 Outperform | |
| Incyte | 3.55% | $39.73K | $23.35B | 74.45% | 81 Outperform | |
| Vertex Pharmaceuticals | 3.30% | $36.96K | $134.02B | 11.98% | 78 Outperform | |
| Workday | 3.14% | $35.20K | $33.44B | -42.62% | 73 Outperform | |
| Synopsys | 3.04% | $34.10K | $83.71B | -17.57% | 73 Outperform | |
| Electronic Arts | 2.78% | $31.19K | $51.46B | 34.59% | 70 Outperform |
QFRD Technical Analysis
Positive
―
Price Trends
27.20
Positive
25.50
Positive
Market Momentum
0.30
Negative
63.72
Neutral
91.53
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QFRD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.50, equal to the 50-day MA of 27.20, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.30 indicates Negative momentum. The RSI at 63.72 is Neutral, neither overbought nor oversold. The STOCH value of 91.53 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QFRD.
QFRD Peer Comparison
Comparison Results
Performance Comparison
QFRD
Pacer S&P 500 Quality FCF R&D Leaders
28.48
3.94
16.06%
ACEP
ARS Core Equity Portfolio ETF
―
―
―
FCUS
Pinnacle Focused Opportunities ETF
―
―
―
JOYT
JPMorgan Equity and Options Total Return ETF
―
―
―
EGGQ
NestYield Visionary ETF
―
―
―
JHDG
John Hancock Hedged Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents